Events, news, and information for the people who influence the business strategies of the life science industry.

China's Challenges and Opportunities in the Wake of COVID-19

Share this article

Discover how pharma companies in China are collaborating like never before to keep the supply chain from breaking, as well as asking the government to help address a flurry of issues laid bare by the public health crisis. Insights into these pressing issues and much more are detailed in the newly released China’s Challenges and Opportunities in the Wake of COVID-19 by Pharma Intelligence.

Download Now -  SPECIAL REPORT: 2019 Biopharma Outlook Facing an Uncertain Future

 

What’s Inside:
  • Rare peek into the policies behind the vaccines race
  • How China reacted to the deficiencies in primary healthcare exposed by COVID-19
  • The impact COVID-19 has had on pharmaceutical supply chains
  • How telecare and telemedicine are valued more than ever

ChinaBio_Partnering_Forum_Digital_Banners_900x100 (002)

Share this article

Upcoming event

BIO-Europe

26 - 29 Oct 2020, European Standard Time
GLOBAL PARTNERSHIPS THAT DRIVE LIFE SCIENCE DEALMAKING
Go to site